📰 John Simard News
Page 2 - John Simard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Simard. Real-time updates on events, politics, business and more.
May 22, 2023
Cue Biopharma (NASDAQ:CUE – Get Rating) and XBiotech (NASDAQ:XBIT – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Analyst Recommendations This is a summary of current ratings and […]
May 21, 2023
StockNews.com started coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research note released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Trading Down 1.8 % Shares of XBiotech stock opened at $4.95 on Wednesday. The company’s 50-day moving average price is $3.50 and its two-hundred day […]
May 18, 2023
Shares of XBiotech Inc. (NASDAQ:XBIT – Get Rating) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.41 and traded as high as $3.48. XBiotech shares last traded at $3.48, with a volume of 49,178 shares. Analyst Ratings Changes Separately, StockNews.com assumed coverage on XBiotech […]
May 13, 2023
StockNews.com began coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a report published on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. XBiotech Price Performance Shares of XBiotech stock opened at $3.35 on Tuesday. The business’s 50 day simple moving average is $3.41 and its two-hundred day simple […]
May 11, 2023
Analysts at StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. XBiotech Trading Up 0.3 % NASDAQ:XBIT opened at $3.29 on Tuesday. The stock has a market capitalization of $100.15 million, a PE […]
May 5, 2023
StockNews.com initiated coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Stock Down 1.5 % Shares of NASDAQ XBIT opened at $3.33 on Monday. The stock has a market cap of $101.36 million, a PE […]
May 4, 2023
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report report published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. XBiotech Price Performance Shares of XBiotech stock opened at $3.38 on Monday. The firm has a market cap of $102.89 million, a price-to-earnings ratio […]
April 27, 2023
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research note published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. XBiotech Stock Performance XBIT opened at $3.06 on Friday. XBiotech has a one year low of $3.00 and a one year high of $9.10. The […]
April 7, 2023
StockNews.com assumed coverage on shares of XBiotech (NASDAQ:XBIT – Get Rating) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. XBiotech Trading Up 3.7 % Shares of XBIT opened at $3.61 on Tuesday. XBiotech has a 1 year low of $3.00 and a […]
March 28, 2023
StockNews.com upgraded shares of XBiotech (NASDAQ:XBIT – Get Rating) from a sell rating to a hold rating in a report issued on Friday morning. XBiotech Stock Performance Shares of NASDAQ:XBIT opened at $3.37 on Friday. The business’s 50 day simple moving average is $3.71 and its two-hundred day simple moving average is $3.61. The firm […]